Spectrum Pharmaceuticals, Inc. Announces Presentation of Eleven (11) Key ZEVALIN Abstracts & Papers at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida on December 4-7, 2010

IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced a total of 11 ZEVALIN related data presentations (five oral, six posters) at the 52nd Annual Meeting of the American Society of Hematology (ASH), being held at the Orange County Convention Center in Orlando, Florida, December 4-7, 2010.

Back to news